Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome
Clinical trial NCT01348087 · TERMINATED
Trial details
- NCT number
- NCT01348087
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-09-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.